Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALS LIMITED Earnings Release 2025

Apr 27, 2025

64365_rns_2025-04-27_856a17f4-4464-41d9-a79e-47c58e30f256.pdf

Earnings Release

Open in viewer

Opens in your device viewer

asx release

==> picture [51 x 55] intentionally omitted <==

28 April 2025

Trading update

ALS Limited (ASX: ALQ) notes the recent market volatility and uncertainty in global markets following the ongoing tariff announcements. ALS advises that there is no immediate and/or material impact on input costs as a direct result of the announced tariffs.

The global or regional hub and spoke operating model within each ALS business stream is flexible enough to continue to provide clients with the expected quality and service during this uncertain market environment. ALS will continue to monitor broader macroeconomic factors and remains focused on adhering to the principles in ALS’ value creation framework.

The audited FY25 financial results (for the year ending 31 March 2025) will be announced on 27 May 2025. In providing a trading update at this time, based on unaudited management results, underlying net profit after tax is expected to be in the range of AUD $310-$313 million.

In Commodities, year on year sample volumes for the Minerals division have improved from being down by approximately 0.5% at the half year (H1 FY25; six months to 30 September 2024) to positive approximately 2.5% at the full year (predominantly delivered in the March quarter; Q4 FY25). The remaining Commodities businesses continued performing as expected in line with the outlook previously provided.

In Life Sciences, the Environmental division delivered approximately 10.0% organic growth for the year. The Food and Pharma divisions are now under new leadership and are being managed as separate business streams, with performance continuing in line with the outlook previously provided. Finally, integrations of recent acquisitions continue to track ahead of expectations.

Authorised for release by the Board of Directors.

For further information please contact:

Michael Williams
Group Treasurer, Investor Relations & Business Integration Director
[email protected]
M: + 61 409 001 308
Investor Relations
[email protected]
ALS Limited

About ALS Limited (ASX: ALQ)

ALS is a global leader in testing, providing comprehensive testing solutions to clients in a wide range of industries around the world. Using state-of-the-art technologies and innovative methodologies, our dedicated international teams deliver the highest-quality testing services and personalised solutions supported by local expertise. We help our clients leverage the power of data-driven insights for a safer and healthier world.

1

alsglobal.com